The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue

Shogo Wada1, Michael Neinast1, Cholsoon Jang1,2

  • 1Department of Medicine and Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

Genes & Development
|December 4, 2016
PubMed

Insights

Folliculin (FLCN) regulates fat browning through a novel mechanistic target of rapamycin (mTOR) pathway involving TFE3 and PGC-1β. This pathway is distinct from the canonical TSC-mTOR-S6K pathway.

Area of Science:

  • Cell Biology
  • Metabolism
  • Molecular Biology

Background:

  • Noncanonical mechanistic target of rapamycin (mTOR) pathways are not well understood.
  • Mutations in tumor suppressor folliculin (FLCN) cause Birt-Hogg-Dubé syndrome, characterized by kidney tumors.
  • FLCN's role in adipose tissue has not been previously explored.

Purpose of the Study:

  • To investigate the role of folliculin (FLCN) in regulating adipose tissue browning.
  • To elucidate the molecular mechanisms by which FLCN influences adipose tissue metabolism.
  • To identify novel pathways regulating adipose tissue browning.

Main Methods:

  • Adipose-specific deletion of FLCN in animal models.
  • Analysis of mTOR signaling and TFE3 localization.
  • Assessment of PGC-1 transcriptional coactivators and adipose tissue browning markers.
  • Genetic manipulation of TFE3 and PGC-1β expression.

Main Results:

  • FLCN deletion in adipose tissue leads to TFE3 release from mTOR-dependent cytoplasmic retention.
  • This results in the induction of PGC-1 coactivators, driving mitochondrial biogenesis and adipose tissue browning.
  • The FLCN-mTOR-TFE3-PGC-1β pathway is independent of canonical TSC-mTOR-S6K signaling.
  • Codeletion of TFE3 or PGC-1β rescues adipose tissue browning in FLCN knockout models.

Conclusions:

  • A novel FLCN-mTOR-TFE3-PGC-1β pathway regulates adipose tissue browning.
  • This pathway is distinct from the canonical TSC-mTOR-S6K pathway.
  • FLCN plays a critical role in controlling adipose tissue metabolism and energy expenditure.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K